Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, and Sheinfeld J. “Pathologic Findings and Clinical Outcomes of Patients Undergoing Retroperitoneal Lymph Node Dissection Following Multiple Chemotherapy Regimens for Metastatic Testicular Germ Cell Tumors.” Cancer, February 2007; 109: 528. Link: http://www.ncbi.nlm.nih.gov/pubmed/17177200
Nadler RB, Loeb S, and Vardi IY. “The Use of BioGlue in Laparoscopic Partial Nephrectomy.” Urology, August 2006; 68: 416. Link: http://www.ncbi.nlm.nih.gov/pubmed/16904466
Nadler RB, Loeb S, Clemens JQ, Batler RA, Gonzalez CM, and Vardi IY. “A Prospective Study on Laparoscopic Radical Nephrectomy: Is Transperitoneal, Retroperitoneal, or Hand-Assisted the Best Approach?” Journal of Urology, April 2006; 175: 1230. Link: http://www.ncbi.nlm.nih.gov/pubmed/16515966
Murphy DG, Loeb S. “Prostate Cancer: Growth of AS in the USA Signals Reduction in Overtreatment.” Nature Reviews Urology 2015 epub. PMID: 26390970. Link: http://www.ncbi.nlm.nih.gov/pubmed/26390970
Makarov DV, Loeb S, Magheli A, Zhao K, Humphreys E, Gonzalgo ML, Partin AW, and Han M. “Significance of Preoperative PSA Velocity in Men with Low Serum PSA and Normal DRE.” World Journal of Urology 2011; 29: 11. Link: http://www.ncbi.nlm.nih.gov/pubmed/21153643
Loeb S and Catalona WJ. “PSA Should Drive Doing Prostate Biopsies.” Urologic Oncology: Seminars and Original Investigations Jan-Feb 2012; 30: 1-2. PMID: 21458316. Link: http://www.ncbi.nlm.nih.gov/pubmed/21458316
Lecture topic: Nuevas marcardores en el cáncer de próstata (en español) Category: prostate cancer Location: via Skype to Venezuela
Hamburg, Germany. January 2015 Lecture Topics : Genomic and Epigenetic Variations in Prostate Cancer Category: Prostate Cancer
USA. October 2015 Lecture Topics: Markers in Prostate Cancer Screening and Active Surveillance, Social Media in Urology Categories: Prostate cancer, Social media
Jerusalem, Israel. September 2015 Lecture Topic: Utilization of Active Surveillance Category: Prostate Cancer
Lisbon, Portugal. September 10-12, 2015 Lecture Topic: Markers in Screening and Active Surveillance Category: Prostate Cancer
Florida, USA. September 2015 Lectures topics: 1) The Dilemma of an Elevated PSA: The Role of New Biomarkers to Determine When to Biopsy, 2) 4K Score, 3) Social Media in Urology Categories: Prostate Cancer, Social Media
Loeb S, Carter HB, Schaeffer EM, Kettermann A, Ferrucci L, and Metter EJ. “Distribution of PSA Velocity by Total PSA Levels: Data from the Baltimore Longitudinal Study of Aging.” Urology January 2011; 77: 143. Link: http://www.ncbi.nlm.nih.gov/pubmed/21195835
Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, and Walsh PC. “Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.” Journal of Clinical Oncology 2010; 28: 2810. Link: http://www.ncbi.nlm.nih.gov/pubmed/20439642
Loeb S, Kan D, Yu X, Roehl KA, and Catalona WJ. “Preoperative Prostate Specific Antigen Doubling Time is Not a Useful Predictor of Biochemical Progression After Radical Prostatectomy.” Journal of Urology, May 2010; 183: 1816. Link: http://www.ncbi.nlm.nih.gov/pubmed/20303104
Loeb S, Trock BJ. “Re: Randomized Prostate Cancer Screening Trial: 20 Year Follow-up.” European Urology 2011; 60: 1306. PMID: 22054407. Link: http://www.europeanurology.com/article/S0302-2838%2811%2900989-4/fulltext/re-randomised-prostate-cancer-screening-trial-20-year-follow-up
Loeb S. “Invited Editorial Comment Re: Variable Prostate-Specific Antigen Management Patterns by Nonurologist Providers at a Tertiary Medical Center.” Urology August 2011; 78: 248. PMID: 21820564. Link: http://www.ncbi.nlm.nih.gov/pubmed/21820564
Loeb S. “Use of Empiric Antibiotics in the Setting of an Increased Prostate Specific Antigen: Pro.” Journal of Urology June 2011; 186: 17. PMID: 21571331. Link: http://www.ncbi.nlm.nih.gov/pubmed/21571331
Loeb S. “Germline Sequence Variants and Prostate Specific Antigen Interpretation.” Clinical Chemistry May 2011; 57: 662-3. PMID: 21411622. Link: http://www.ncbi.nlm.nih.gov/pubmed/21411622
Loeb S. Editorial Comment on “Prostate-Specific Antigen Density: Toward a Better Cutoff to Identify Better Candidates for Active Surveillance.” Urology 2014; 84: 371. Link: http://www.ncbi.nlm.nih.gov/pubmed/24925831
Loeb S, Carter HB. “Point: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendations.” Journal of the National Comprehensive Cancer Network 2013; 11: 281. PMID: 23486454 Link: http://www.ncbi.nlm.nih.gov/pubmed/23486454
Loeb S. “Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker?” European Urology epub 2013 Feb 14. PMID: 23453055 Link: http://www.ncbi.nlm.nih.gov/pubmed/23453055
Le BV, Griffin CR, Loeb S, Carvalhal GF, Kan D, Baumann NA, and Catalona WJ. “[-2] Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.” Journal of Urology 2010; 183: 1355. Link: http://www.ncbi.nlm.nih.gov/pubmed/20171670
Loeb S. “Prostate Cancer: Prostate Health Index- Improving Screening in Men with a Positive Family History.” Nature Reviews in Urology 2013; 10: 497 Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943368/
Tosoian JJ, Loeb S, Kettermann A, Landis P, Elliot DJ, Epstein JI, Partin AW, Carter HB, and Sokoll LJ. “Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program.” Journal of Urology, February 2010; 183: 534. Link: http://www.ncbi.nlm.nih.gov/pubmed/20006883
Loeb S, Roehl KA, Helfand BT, Kan D, and Catalona WJ. “Can PSA Velocity Thresholds Reduce the Detection of Insignificant Prostate Cancer?” Journal of Urology 2010; 183: 112. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140466/
Kettermann AE, Ferrucci L, Trock BJ, Metter EJ, Loeb S and Carter HB. “Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.” BJU International 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928882/
Loeb S and Catalona WJ “Prostate-specific antigen screening: pro.” Current Opinion in Urology, May 2010; 20: 185. Link: http://www.ncbi.nlm.nih.gov/pubmed/20224413
Loeb S, Montorsi F, Catto JW. “Future-Proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?” European Urology 2015 epub. PMID: 25769986. Link: http://www.ncbi.nlm.nih.gov/pubmed/25769986
Loeb S. “An Examination of the Dynamic Changes in Prostate-Specific Antigen Occurring in a Population-Based Cohort of Men Over Time.” BJU International August 2012; 110: 381-2. PMID: 22313542. Link: http://www.ncbi.nlm.nih.gov/pubmed/22313542
Loeb S and Catalona WJ. “Prostate Cancer: Utility of the Riskindicator Model in Screening.” Nature Reviews Urology, April 2010; 7: 184. Link: http://www.ncbi.nlm.nih.gov/pubmed/20383184
Loeb S. “Editorial comment re: Longitudinal Changes of Benign Prostate-Specific Antigen and [-2]ProProstate-Specific Antigen in Seven Years in a Community-Based Sample of Men.” Urology, March 2012; 79: 661. PMID: 22386421. Link: http://www.ncbi.nlm.nih.gov/pubmed/22386421
Loeb S. Editorial comment re: “Prostate Specific Antigen Velocity per Prostate Volume: A Novel Tool for Prostate Biopsy Prediction.” Urology 2011; 78: 879. PMID: 21982006 Link: http://www.ncbi.nlm.nih.gov/pubmed/21982006
Loeb S and Partin AW. “What is the true mortality benefit of prostate-specific antigen screening?” Reviews in Urology, Winter 2010; 12: 66. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859145/
Tel Aviv, Israel. July 2012 Lecture Topic: Prostate Cancer Screening Category: Prostate Cancer
Punta Cana, Dominican Republic. November 2013 Lectures Topics: PSA Screening, Prostate Cancer Markers, and Prostate Biopsy Complications Category: Prostate Cancer
Amsterdam, Netherlands. February 2014 Lecture topic: Risk based prediction models for indolent Prostate Cancer Category: Prostate Cancer
Moscow, Russia. March 2014 Lecture topic: PSA Screening Cost-Effectiveness, Prostate Cancer Markers Category: Prostate Cancer
San Jose, Costa Rica. August 2014 Lectures on: Active surveillance for prostate cancer, Highlights of the AUA meeting on Localized Prostate Cancer Category: Prostate Cancer
Manila, Philippines. September 2014 Lectures topic: Smarter PSA screening, Novel Prostate Cancer Markers, and Active Surveillance Category: Prostate Cancer